Skip to main content

WELLS FARGO & COMPANY/MN

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 72971 SAN FRANCISCO, CA

Position in BCRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,228,940
-$26,737 QoQ
Shares Held
222,894
-5.9% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 316 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $472,275,691 across 58 Drug Manufacturers - Specialty & Generic names. BCRX ranks #26 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BCRX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,228,940 222,894
2026-03-31 $2,255,677 236,941
2025-12-31 $1,822,383 233,639
2025-09-30 $1,009,741 133,036
2025-06-30 $2,552,980 284,931
2025-03-31 $1,635,629 218,084
2024-12-31 $783,305 104,163
2024-09-30 $516,776 67,997
2024-06-30 $447,703 72,444
2024-03-31 $318,296 62,657
2023-12-31 $334,473 55,839
2023-09-30 $1,360,703 192,190
2023-06-30 $1,799,993 255,681
2023-03-31 $1,534,133 183,949
2022-12-31 $112,801 9,826
2022-09-30 $217,310 17,247
2022-06-30 $239,866 22,672
2022-03-31 $2,519,517 154,952
2021-12-31 $2,994,285 216,194
2021-09-30 $2,885,078 200,771
2021-06-30 $3,176,717 200,931
2021-03-31 $2,052,294 201,799
2020-12-31 $3,519,206 472,377
2020-09-30 $1,612,278 468,686
2020-06-30 $2,285,379 480,122
2020-03-31 $184,826 92,413